TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Pelago Bioscience AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
7,893
|
7,440
|
7,220 |
| Financial expenses |
1
|
5
|
2 |
| Earnings before taxes |
-638
|
515
|
979 |
| EBITDA |
-492
|
979
|
1,372 |
| Total assets |
8,277
|
6,441
|
5,936 |
| Current assets |
5,535
|
5,098
|
4,134 |
| Current liabilities |
3,084
|
3,406
|
3,129 |
| Equity capital |
5,185
|
2,810
|
2,590 |
| - share capital |
10
|
5
|
5 |
| Employees (average) |
52
|
51
|
39 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
62.6%
|
43.6%
|
43.6% |
| Turnover per employee |
152
|
146
|
185 |
| Profit as a percentage of turnover |
-8.1%
|
6.9%
|
13.6% |
| Return on assets (ROA) |
-7.7%
|
8.1%
|
16.5% |
| Current ratio |
179.5%
|
149.7%
|
132.1% |
| Return on equity (ROE) |
-12.3%
|
18.3%
|
37.8% |
| Change turnover |
432
|
804
|
1,079 |
| Change turnover % |
6%
|
12%
|
18% |
| Chg. No. of employees |
1
|
12
|
12 |
| Chg. No. of employees % |
2%
|
31%
|
44% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.